109 related articles for article (PubMed ID: 26555890)
21. A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan.
Qamar FN; Azmatullah A; Kazi AM; Khan E; Zaidi AK
J Infect Dev Ctries; 2014 Aug; 8(8):981-6. PubMed ID: 25116662
[TBL] [Abstract][Full Text] [Related]
22. Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.
Pan Q; Zhang XL; Wu HY; He PW; Wang F; Zhang MS; Hu JM; Xia B; Wu J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4052-60. PubMed ID: 16189080
[TBL] [Abstract][Full Text] [Related]
23. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
24. Analysis and construction of pathogenicity island regulatory pathways in Salmonella enterica serovar Typhi.
Ong SY; Ng FL; Badai SS; Yuryev A; Alam M
J Integr Bioinform; 2010 Sep; 7(1):. PubMed ID: 20861532
[TBL] [Abstract][Full Text] [Related]
25. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
26. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
27. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi.
Holt KE; Parkhill J; Mazzoni CJ; Roumagnac P; Weill FX; Goodhead I; Rance R; Baker S; Maskell DJ; Wain J; Dolecek C; Achtman M; Dougan G
Nat Genet; 2008 Aug; 40(8):987-93. PubMed ID: 18660809
[TBL] [Abstract][Full Text] [Related]
28. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
29. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
Mengo DM; Kariuki S; Muigai A; Revathi G
J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
[TBL] [Abstract][Full Text] [Related]
30. Biochemical, immunochemical and immunobiological properties of a chloramphenicol-resistant Salmonella typhi strain isolated in Mexico.
Joó I; Auber E; Varró R; Zalay L
Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):470-85. PubMed ID: 1221675
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomic analysis between typhoidal and non-typhoidal Salmonella serovars reveals typhoid-specific protein families.
Zou QH; Li RQ; Liu GR; Liu SL
Infect Genet Evol; 2014 Aug; 26():295-302. PubMed ID: 24951835
[TBL] [Abstract][Full Text] [Related]
32. Characterization of putative multidrug resistance transporters of the major facilitator-superfamily expressed in Salmonella Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; De Zorzi R; Mirza O; Walz T; Rahman M
J Infect Chemother; 2015 May; 21(5):357-62. PubMed ID: 25724589
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
34. Genomic dissection of travel-associated extended-spectrum-beta-lactamase-producing Salmonella enterica serovar typhi isolates originating from the Philippines: a one-off occurrence or a threat to effective treatment of typhoid fever?
Hendriksen RS; Leekitcharoenphon P; Mikoleit M; Jensen JD; Kaas RS; Roer L; Joshi HB; Pornruangmong S; Pulsrikarn C; Gonzalez-Aviles GD; Reuland EA; Al Naiemi N; Wester AL; Aarestrup FM; Hasman H
J Clin Microbiol; 2015 Feb; 53(2):677-80. PubMed ID: 25428145
[TBL] [Abstract][Full Text] [Related]
35. [Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008].
Bouzenoune F; Kellab Debbih K; Boudersa F; Kouhil S; Nezzar N
Med Mal Infect; 2011 Apr; 41(4):181-5. PubMed ID: 21093188
[TBL] [Abstract][Full Text] [Related]
36. Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant
Mujawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2018; 8():402. PubMed ID: 30488026
[TBL] [Abstract][Full Text] [Related]
37. Molecular evaluation of drug resistance in clinical isolates of Salmonella enterica serovar Typhi from Pakistan.
Afzal A; Sarwar Y; Ali A; Maqbool A; Salman M; Habeeb MA; Haque A
J Infect Dev Ctries; 2013 Dec; 7(12):929-40. PubMed ID: 24334939
[TBL] [Abstract][Full Text] [Related]
38. Report of a Salmonella enterica serovar Typhi isolate from India producing CMY-2 AmpC β-lactamase.
Kumarasamy K; Krishnan P
J Antimicrob Chemother; 2012 Mar; 67(3):775-6. PubMed ID: 22146877
[No Abstract] [Full Text] [Related]
39. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal.
Tamang MD; Oh JY; Seol SY; Kang HY; Lee JC; Lee YC; Cho DT; Kim J
Int J Antimicrob Agents; 2007 Oct; 30(4):330-5. PubMed ID: 17629465
[TBL] [Abstract][Full Text] [Related]
40. Massive lineage replacements and cryptic outbreaks of Salmonella Typhi in eastern and southern Africa.
Wirth T
Nat Genet; 2015 Jun; 47(6):565-7. PubMed ID: 26018894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
